CLL expressing low levels of the BACH2 and BCL6 RNA had a significantly shorter overall survival (OS) than those expressing high levels (p-value = 0.005 and p-value = 0.04, respectively) (Figure 2 and Figure 3). This evidence concerns the gene BCL6 and B-cell chronic lymphocytic leukemia.